Though our target is a billion doses, we may have an upside as we are evaluating various doses in the phase-1 and -2 studies, said Datla
from Latest News https://ift.tt/3iFqXFH
Thursday, 8 October 2020
We can make over 1.5 bn doses in 2021: Biological E MD & CEO Mahima Datla
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment